This standard specifies the application principles, application methods, doses and indications for discontinuation of hematopoietic stimulating factors in the treatment of acute radiation sickness caused by external exposure. This standard is applicable to the treatment of acute radiation sickness and hematopoietic system damage caused by external radiation sickness caused by accidental whole-body exposure. It can also be used as a reference for hematopoietic system damage caused by tumor patients after radiotherapy and chemotherapy.
WS/T 378-2013 Referenced Document
GB/T 18199 Medical management and treatment programme for personnel exposed to accidental external irradiation
GBZ 104 Diagnostic criteria for acute radiation sickness from external exposure
WS/T 378-2013 history
2013WS/T 378-2013 Application specification of hematopoietic stimulating factor on the treatment of acute radiation sickness